In today’s Health Headlines, what you need to know about epilepsy — including how to recognize a seizure, how to help someone ...

The diagnosis: The man appeared to be having clonic seizures — repeated jerking movements — in his arm while solving sudoku, ...

Detailed price information for Xenon Pharmaceuticals Inc (XENE-Q) from The Globe and Mail including charting and trades.

The results of a new study finds that “CBD may reduce seizure frequency in patients with a range of DEEs (epileptic ...

Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using Biohaven's proprietary MoDE and next-generation, highly selective ...

Xenon Pharmaceuticals Inc. , a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical ...

February 2026 for ulixacaltamide in essential tremor and relutrigine in SCN2A/8A-DEEs, both with Breakthrough Therapy ...

Detailed price information for Rapport Therapeutics Inc (RAPP-Q) from The Globe and Mail including charting and trades.

The Naox Link system uses soft, biocompatible in-ear electrodes integrated into wired earbuds to acquire, record, and ...

Rapport Therapeutics announced in early January 2026 that the FDA has cleared RAP-219 to move into Phase 3 registrational ...

Purpose: To determine the frequency band-related local functional connectivity (BRLFC) of the seizure onset area (SOA) and areas removed from it, and the relationship between BRLFC and outcome of ...

U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated initiation of Phase 3 program expected in the second ...